09939 KINTOR PHARMA-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.43X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.5% | Net Margin | N/A |
| Total Debt/Equity | 47.4% | Return on Equity | N/A |
| Price/Book | 6.48X | Return on Assets | N/A |
| (HKD 2.640) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -222.74 | -165.15 | -1,169.24 | -1,070.04 | -1,029.97 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -34.9 | +85.9 | -9.3 | -3.9 | -70.7 |
| Earnings Per Share (HKD) | -0.495 | -0.383 | -2.725 | -2.842 | -2.89 |
| Earnings Per Share Growth (%) | -29.2 | +85.9 | +4.1 | +1.7 | -48.2 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.408 | 0.699 | 1.128 | 3.746 | 5.223 |
| Auditors' Opinion | N/A | Unqualified # | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-03 21:40:22
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 32.682 | 5 | +553.6 | 0 |
| Operating Result | -203.725 | -156.365 | +30.3 | -1,069 |
| Associates | 0.766 | -1.429 | -153.6 | 0.052 |
| Profit Before Taxation | -202.959 | -155.274 | +30.7 | -1,069 |
| Taxation | -2.852 | 0.018 | -15,944.4 | -8.041 |
| Profit /( Loss) After Taxation | -200.107 | -155.292 | +28.9 | -1,061 |
| Net Profit | -200.107 | -155.292 | +28.9 | -1,061 |
| Earnings Per Share () | -0.4952 | -0.3834 | +29.2 | -2.7251 |
| Announcement Date | 2026-03-30 | 2025-03-26 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-03 21:40:27
